PremiumCompany AnnouncementsANGLE plc Announces Breakthrough in Cancer Treatment via Parsortix System ANGLE plc’s HER2 Assay Gains Independent Validation at San Antonio Symposium ANGLE plc Showcases New HER2 Assay Developments PremiumCompany AnnouncementsANGLE plc’s Parsortix System Hits 100 Publications Milestone ANGLE plc Pivots to Pharma Services with Promising Outlook ANGLE Inks Deal for Advanced Cancer Sequencing Tech PremiumCompany AnnouncementsANGLE’s Parsortix Enhances Melanoma Mutation Detection Global Frontier Ups Stake in ANGLE plc ANGLE plc Announces Major Share Ownership Shift